Endothelial vasodilator production by uterine and systemic arteries. IV. Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep
Da. Habermehl et al., Endothelial vasodilator production by uterine and systemic arteries. IV. Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep, BIOL REPROD, 62(3), 2000, pp. 781-788
Uterine artery endothelial production of the potent vasodilator, prostacycl
in, is greater in pregnant versus nonpregnant sheep and in whole uterine ar
tery from intact versus ovariectomized ewes, We hypothesized that uterine a
rtery cyclooxygenase (COX)-1 and/or COX-2 expression would be elevated duri
ng pregnancy (high estrogen and progesterone) and the follicular phase of t
he ovarian cycle (high estrogen/low progesterone) as compared to that in lu
teal phase (low estrogen/high progesterone) or in ovariectomized (low estro
gen and progesterone) ewes, Uterine and systemic (omental) arteries were ob
tained from nonpregnant luteal-phase (LUT; n = 10), follicular-phase (FOL;
n = 11), and ovariectomized (OVEX; n = 10) sheep, as well as from pregnant
sheep (110-130 days gestation; term = 145 +/- 3 days; n = 12). Endothelial
and vascular smooth muscle (VSM) COX-1 protein levels and uterine artery en
dothelial cell COX-1 mRNA levels were compared, Using immunohistochemistry
and Western analysis, the primary location of COX-1 protein was the endothe
lium; that is, we observed 2.2-fold higher COX-1 protein levels in intact v
ersus endothelium-denuded uterine artery and a 6.1-fold higher expression i
n the endothelium versus VSM (P < 0.05), COX-2 protein expression was not d
etectable in either uterine artery endothelium or VSM, COX-1 protein levels
were observed to be higher (1.5-fold those of LUT) in uterine artery endot
helium from FOL versus either OVEX or LUT nonpregnant ewes (P < 0.05), with
substantially higher COX-1 levels seen in pregnancy (4.8-fold those of LUT
), Increases in uterine artery endothelial COX-1 protein were highly correl
ated to increases in the level of COX-1 mRNA (r(2) = 0.66; P < 0.01) for al
l treatment groups (n = 6-8 per group), suggesting that increased COX-1 pro
tein levels are regulated at the level of increased COX-1 mRNA, No change i
n COX-1 expression was observed between groups in a systemic (omental) arte
ry, In conclusion, COX-1 expression is specifically up-regulated in the ute
rine artery endothelium during high uterine blood flow states such as the f
ollicular phase and, in particular, pregnancy.